MedPath

Desflurane

Generic Name
Desflurane
Brand Names
Suprane
Drug Type
Small Molecule
Chemical Formula
C3H2F6O
CAS Number
57041-67-5
Unique Ingredient Identifier
CRS35BZ94Q

Overview

Desflurane, or I-653, a a volatile anesthetic that is more rapidly cleared and less metabolized than previous inhaled anesthetics such as methoxyflurane, sevoflurane, enflurane, or isoflurane.. It was developed in the late 1980s out of a need for a more rapidly acting and rapidly cleared inhaled anesthetic. Desflurane was granted FDA approval on 18 September 1992.

Background

Desflurane, or I-653, a a volatile anesthetic that is more rapidly cleared and less metabolized than previous inhaled anesthetics such as methoxyflurane, sevoflurane, enflurane, or isoflurane.. It was developed in the late 1980s out of a need for a more rapidly acting and rapidly cleared inhaled anesthetic. Desflurane was granted FDA approval on 18 September 1992.

Indication

Desflurane is indicated for the induction and maintenance of anesthesia in adults, as well as the maintenance of anesthesia in pediatric patients.

Associated Conditions

No associated conditions information available.

FDA Approved Products

SUPRANE
Manufacturer:Baxter Healthcare Corporation
Route:RESPIRATORY (INHALATION)
Strength:240 mL in 240 mL
Approved: 2023/02/22
NDC:10019-641
Suprane
Manufacturer:General Injectables & Vaccines, Inc
Route:RESPIRATORY (INHALATION)
Strength:240 mL in 240 mL
Approved: 2022/12/27
NDC:52584-641
SUPRANE
Manufacturer:Baxter Healthcare Corporation
Route:RESPIRATORY (INHALATION)
Strength:240 mL in 240 mL
Approved: 2015/02/26
NDC:10019-646
Desflurane
Manufacturer:Piramal Critical Care Inc
Route:RESPIRATORY (INHALATION)
Strength:250 mL in 250 mL
Approved: 2023/02/28
NDC:66794-021
Suprane
Manufacturer:Baxter Healthcare Corporation
Route:RESPIRATORY (INHALATION)
Strength:240 mL in 240 mL
Approved: 2015/02/26
NDC:10019-644

Singapore Approved Products

SUPRANE INHALATION ANAESTHETIC
Manufacturer:Baxter Healthcare Corporation
Form:SOLUTION
Strength:100%
Online:Yes
Approved: 1996/08/06
Approval:SIN08818P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath